- Filed
- May 14, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 12, 2026 | 34.74M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 35.55M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 27.58M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $2.38M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$4.32M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $40.18M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $36.79M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $37.68M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $35.47M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | −$5.88M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | −$5.87M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $9.59M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $10.52M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $34.15M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $35.08M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $66.88M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $67.04M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $71.82M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $70.55M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.01 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.04 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.01 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.04 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $3.19M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $5.87M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $49K |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $94K |
| Net Income | Q1 2026 · Mar 31, 2026 | $201K |
| Net Income | Q1 2026 · Mar 31, 2025 | −$1.17M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$119K |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$808K |
| Revenue | Q1 2026 · Mar 31, 2026 | $15.11M |
| Revenue | Q1 2026 · Mar 31, 2025 | $8.75M |